Skip to main content
. Author manuscript; available in PMC: 2012 May 10.
Published in final edited form as: J Alzheimers Dis. 2011;25(1):119–133. doi: 10.3233/JAD-2011-102025

Table 1.

Antibodies

Group Antibody Epitope Dilution
Source
IB IF IHC ELISA
Abl 2411 c-Abl C-terminus 1 : 1000 Santa Cruz
K12 c-Abl kinase domain 1 : 2000 1 : 4000 Santa Cruz
pY412 c-Abl pY412 1 : 1000 Cell Signaling
Arg AR19 Arg N-terminus 1 : 500 1 : 1000 Peter Davies
AR23 Abl, Arg N-terminus 1 : 1000 Peter Davies
P-Tyr 4 G10 Phospho-tyrosine 1 : 1000 1 : 1000 1 : 5000 (tau) Millipore
1 : 1000 (Abl)
Neurons NeuN NeuN 1 : 10000 Millipore
Astrocytes GFAP GFAP 1 : 1000 1 : 500 Invitrogen
Microglia Iba-1 Iba-1 1 : 1000 Wako
Tau DA31 Tau, 150–190 Coating 2 μg/ml Peter Davies
PHF-1 Tau pS396/pS404 1 : 5000 Peter Davies
CP13 Tau pS202 1 : 5000 Peter Davies
MC-1 Tau, 5–15, 312–322 1 : 200 Peter Davies
YP4 Tau pY394, pS396 1 : 100 Peter Davies
DA9* Tau, 102–150 1 : 5000 Peter Davies
Amyloid 4G8 β-amyloid,17–24 1 : 1000 Covance
*

Biotinylated.

HHS Vulnerability Disclosure